Asymptomatic Myeloma Prognosis
Predicts risk of progression of asymptomatic (smoldering) multiple myeloma to active myeloma or amyloidosis.
Result:
Please fill out required fields.
Dr. Robert A. Kyle
About the creator
Robert A. Kyle, MD, is a professor of medicine and laboratory medicine and pathology at the Mayo Clinic in Rochester, Minnesota. He is widely regarded as a pioneer in multiple myeloma research, having published numerous critical papers on topics including monoclonal gammopathies, multiple myeloma, amyloidosis, and macroglobulinemia.
To view Dr. Robert A. Kyle's publications, visit PubMed
Are you Dr. Robert A. Kyle? Send us a message to review your photo and bio, and find out how to submit Creator Insights!
MDCalc loves calculator creators – researchers who, through intelligent and often complex methods, discover tools that describe scientific facts that can then be applied in practice. These are real scientific discoveries about the nature of the human body, which can be invaluable to physicians taking care of patients.
Content Contributors
- Randall Pierce, MD